Skip to content
HowShorted

Ginkgo Bioworks Holdings, Inc. short interest in 2023

In 2023, Ginkgo Bioworks Holdings, Inc.'s disclosed short interest ran from 6.47% of shares outstanding on 13 Jan 2023 to 11.12% on 29 Dec 2023, a change of +4.65 percentage points. The year's high was 11.85% on 15 Sep 2023 and its low 6.37% on 31 Jan 2023, averaging 9.82% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.27 days on 30 Nov 2023. Full history: Ginkgo Bioworks Holdings, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Ginkgo Bioworks Holdings, Inc. in 2023

2023 in figures

Start of year
6.47% (13 Jan 2023)
End of year
11.12% (29 Dec 2023)
Change
+4.65 pp
High
11.85% (15 Sep 2023)
Low
6.37% (31 Jan 2023)
Average
9.82%
Highest days to cover
15.27 (30 Nov 2023)
SEC filings marked
9

Every report in 2023

Ginkgo Bioworks Holdings, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20236.47%5.79results (8-K)
31 Jan 20236.37%6.84
15 Feb 20236.45%6.48
28 Feb 20237.53%6.69
15 Mar 20238.87%6.80results (8-K), 10-K filed
31 Mar 20239.87%11.36
14 Apr 202310.08%12.85
28 Apr 20239.63%10.60
15 May 20239.70%10.7410-Q filed, results (8-K)
31 May 20238.79%6.98
15 Jun 20238.87%6.98
30 Jun 202310.69%9.32
14 Jul 202310.44%9.10
31 Jul 202310.84%10.04
15 Aug 202310.43%9.1110-Q filed, results (8-K)
31 Aug 202310.47%9.04
15 Sep 202311.85%11.89
29 Sep 202311.80%12.21
13 Oct 202311.66%13.26
31 Oct 202311.14%14.66
15 Nov 202310.52%9.0210-Q filed, results (8-K)
30 Nov 202310.88%15.27
15 Dec 202311.29%10.14
29 Dec 202311.12%12.08

See also: Ginkgo Bioworks Holdings, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.